Company / Working Capital per Share
Esperion Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.78
FY2025
5-year range
$0.43 / $9.44
FY2021-FY2025
Trend
+58.7%
vs FY2024
Sector context
#187 of 210
Health Care
What the data says
Esperion Therapeutics, Inc.'s working capital per share of $0.78 is lower than 89% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $0.43 in FY2023 to $9.44 in FY2021.
Based on SEC 10-K filings.
0.78 in FY2025 with a 5-year CAGR of -38.9%.
Improved from $0.43 to $0.78 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -30.6%
- 5-Year CAGR
- -38.9%
- 10-Year CAGR
- -
Sector benchmark
-99.5% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 58.7% year-over-year.
- Ranks #187 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | +58.7% |
| FY2024 | $0.49 | +12.7% |
| FY2023 | $0.43 | -81.3% |
| FY2022 | $2.32 | -75.4% |
| FY2021 | $9.44 | +3.0% |
| FY2020 | $9.16 | +68.7% |
| FY2019 | $5.43 | +85.5% |
| FY2018 | $2.93 | -59.0% |
| FY2017 | $7.14 | -18.7% |
| FY2016 | $8.78 | -7.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026